Oral Administration of PF-01247324, a Subtype-Selective Nav1.8 Blocker, Reverses Cerebellar Deficits in a Mouse Model of Multiple Sclerosis
Shields, Shannon D., Butt, Richard P., Dib-Hajj, Sulayman D., Waxman, Stephen G., Taylor, BradleyVolume:
10
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0119067
Date:
March, 2015
File:
PDF, 205 KB
english, 2015